Media Information_News Center_FUSEN PHARMACEUTICAL

Fusen News | [Translated from: Hengqin Online] Sichuan Australia Joins Hands, Traditional Chinese Medicine Innovation Project Landing in Hengqin!

19 2023.06

Zhang Boli: The availability of Chinese medicine is most worthy of recognition in the war against the "epidemic"

Nanning, October 16 (Lin Jieqi) Academician of the Chinese Academy of Engineering and Honorary President of Tianjin University of Traditional Chinese Medicine Zhang Boli stated in Nanning on the 16th that “in the fight against the new crown pneumonia epidemic, the accessibility of traditional Chinese medicine is most worthy of recognition. Under the circumstances, Chinese medicine fights for the vitality of patients and the nation." On the same day, the 2021 academic annual meeting of the Cardiovascular Branch of the Chinese Society of Chinese Medicine was held in Nanning, Guangxi, and Zhang Boli delivered a speech at the meeting. He said that at present, the epidemic situation in various parts of China is still spreading in many places. During the period, the use of traditional Chinese medicine treatment methods has achieved good results in the repeated anti-epidemic tests. Zhang Boli said that the new crown pneumonia epidemic is still in a pandemic. The good news is that in the past more than a month, the epidemic has slowed down globally. The domestic epidemic situation is dynamically cleared, but judging from the outbreaks in Jiangsu, Fujian, Heilongjiang, Inner Mongolia and other places, multiple outbreaks have occurred from time to time. He said that China still needs to tighten the string of epidemic prevention and do a good job of "preventing foreign imports and internal defenses against rebound" and cannot be taken lightly. Zhang Boli said that after TCM syndrome analysis, it is determined that the new coronary pneumonia is a "damp virus disease." Zhang Boli recalled his anti-epidemic experience in Wuhan and said that Chinese medicine emphasizes "dialectical treatment", but Wuhan is a special situation. Faced with thousands of patients, it is impossible to dialectical evidence one by one, and can only adopt similar symptoms caused by the same virus. , Use traditional Chinese medicine to treat. At the same time, the establishment of a system of intervention, the formation of traditional Chinese medicine wards, and the use of integrated traditional Chinese and Western medicine for treatment. Under the emergency situation of the Wuhan epidemic at that time, Zhang Boli and his team could only "build roads with old medicines" and screened nearly 60 kinds of Chinese medicines within 10 days, all of which have a certain inhibitory effect on new coronary pneumonia. At the same time, Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Xuebijing Injection, Qingfei Paidu Recipe, Xuanfei Baidu Recipe, and Huashibaidu Recipe were developed with outstanding effects. "Traditional Chinese medicine has thousands of years of anti-epidemic history. It has summarized a wealth of clinical experience. It is indeed effective and convenient." Zhang Boli said. Traditional Chinese medicine decoctions such as "Maxing Shigan Decoction" and "Maxing Ligan Decoction" are also anti-epidemic. It was widely used during the period. Zhang Boli said that Chinese medicine has played an important role in fighting the epidemic and has also promoted its own development. In order to promote the inheritance and innovation of traditional Chinese medicine, relevant national ministries and commissions have issued plans to focus on supporting the National Traditional Chinese Medicine Center, Regional Traditional Chinese Medicine Medical Centers, National Traditional Chinese Medicine Inheritance Innovation Center, National Traditional Chinese Medicine Epidemic Prevention and Control Base, "flagship" hospitals of collaboration between Chinese and Western medicine, and key hospitals with Chinese medicine characteristics With the construction of the famous doctor hall, Chinese medicine has ushered in new development opportunities. In order to promote the development of traditional Chinese medicine in the post-epidemic era, Zhang Boli stated that it is necessary to create new evidence-based evaluation methods that meet the characteristics of traditional Chinese medicine based on the concept of evidence-based medicine, strengthen the training of integrated Chinese and Western talents, and jointly build and share alliances through Chinese herbal medicine bases to promote standardized cultivation of Chinese medicine , To promote the high-quality development of Chinese medicine.

18 2021.10

Zhang Boli: The availability of Chinese medicine is most worthy of recognition in the war against the "epidemic"

Why can Chinese medicine treat the new crown? Zhang Boli said this

On September 27, the Propaganda Department of the Central Committee of the Communist Party of China held a meeting with Chinese and foreign reporters. Representatives of Party members of the health system met and exchanged views with Chinese and foreign reporters on "all for the health of the people". At the meeting, a reporter asked about the role of Chinese medicine in fighting the epidemic. Zhang Boli, academician of the Chinese Academy of Engineering and honorary president of Tianjin University of Traditional Chinese Medicine, responded to this. Zhang Boli said that in this anti-epidemic process, Chinese medicine has participated in the whole process and played an important role in all stages. Through this fight against the epidemic, everyone has strengthened their belief in and love for Chinese medicine. Traditional Chinese medicine is a treasure of the Chinese nation, and it has left a lot of valuable experience for thousands of years, which is worth cherishing. General Secretary Xi Jinping requires traditional Chinese medicine workers to maintain integrity and innovate. They must pass on good experience, and at the same time endow them with the connotation of the times. They must use modern science to interpret traditional Chinese medicine and interpret its treatment principles. This is the direction everyone has been working hard on. The answers to why Chinese medicine can cure diseases, and that it can produce high-level evidence-based evidence, are all done by everyone. Zhang Boli said that it has now been revealed why Chinese medicine can treat the new crown-mainly regulating immune function, allowing the immune function to be properly activated without overactivation, suppressing the inflammatory storm, and preventing it from turning into a severe disease. This is the key link. At the same time, it protects the damaged organs. Of course, there are also studies that have confirmed that it has a certain effect on suppressing the coronavirus and preventing virus replication. Therefore, the use of Chinese medicine is a comprehensive regulation of multiple targets. "This also reveals that we insist on taking the road of modernization of Chinese medicine, which is to integrate with modern technology. The concept of ancient Chinese medicine does not lag behind, and it is behind technology. How to combine with modern technology to promote better Chinese medicine To serve the construction of a healthy China, benefit the Chinese people, and benefit the world."

28 2021.09

Why can Chinese medicine treat the new crown? Zhang Boli said this

7 departments issued notices to support the development of Chinese medicine in the country. The 2 trillion market needs to be stepped up to tap the value of pharmaceuticals

A few days ago, the Ministry of Commerce, the State Administration of Traditional Chinese Medicine and other seven departments jointly issued the "Notice on Several Measures to Support the High-Quality Development of National Traditional Chinese Medicine Service Export Bases", from improving the system and mechanism, innovating supporting policies, enhancing the level of facilitation, and expanding international cooperation. Put forward 18 specific policy measures in five aspects: space, strengthening of talent training and incentives, focus on improving the development environment, form a joint departmental policy, support the national Chinese medicine service export base to vigorously develop Chinese medicine service trade, and promote Chinese medicine service to the world. Subsequently, the National Health Commission issued the "Opinions on Further Strengthening the Work of Traditional Chinese Medicine in General Hospitals to Promote the Coordinated Development of Traditional Chinese and Western Medicine." The notice emphasized that to further enhance awareness, public general hospitals should have hospital leaders who are relatively fixed in charge of traditional Chinese medicine work, and create conditions for the coordinated development of traditional Chinese and Western medicine; the health administration department should include the integration of traditional Chinese and Western medicine in the hospital review and public hospital performance evaluation , To promote the development of Chinese medicine in general hospitals. The development of Chinese medicine ushered in opportunities of the times Recently, the Ministry of Commerce, the State Administration of Traditional Chinese Medicine and other seven departments jointly issued the "Notice on Several Measures to Support the High-Quality Development of National Traditional Chinese Medicine Service Export Bases." Existing channels such as the guidance fund will increase support for the development of Chinese medicine service trade, support the base to expand international marketing channels, achieve high-quality development, and enhance the international influence of Chinese medicine. With the support of many countries' favorable policies and the fact that various localities place TCM work in a more prominent position, industry analysts believe that the inheritance and innovative development of TCM has clearly entered a new stage and embarked on a new journey. For example, from the national level to the local level, the overall plan for the development of Chinese medicine shows that the speed of innovation, research and development and industrial upgrading of Chinese medicine enterprises is accelerating, and it has begun to enter the golden period of development. The industry believes that in this context, Chinese medicine companies need to take advantage of the situation, take responsibility, inherit the essence, maintain integrity and innovation, promote the revitalization and development of Chinese medicine, and make more contributions to the health and well-being of the people and the building of a healthy China. Buchang Pharmaceuticals, as a leading Chinese medicine company, has driven the rapid development of the Chinese medicine industry and has also benefited a lot from the wave of Chinese medicine. While favorable policies for the Chinese medicine industry are frequently emerging, Buchang Pharmaceuticals seizes opportunities and adheres to the fundamentals while expanding into new areas. Not only does it grow steadily in business, it also makes contributions to the well-known pharmaceutical companies in China's Chinese medicine industry. . According to the first quarter of 2021, Buchang Pharmaceutical's research and development expenses were 78 million yuan, a year-on-year increase of 62.58%; sales expenses were 1.651 billion yuan, a year-on-year decrease of 18.78%. "One increase and one decrease" reflects the transformation process of Buchang Pharmaceutical. According to estimates by industry insiders, the development of the Chinese medicine industry will usher in good development opportunities. According to the "In-depth Research and Investment Prospect Analysis Report of the Traditional Chinese Medicine Industry Market in 2021-2025" released by the New Thinking Industry Research Center, the scale of China's traditional Chinese medicine manufacturing market has increased from 64 billion yuan to 73.5 billion yuan from 2016 to 2020. , The average annual compound growth rate reached 3.6% or more. Driven by favorable policies, the size of the Chinese medicine market is expected to reach more than 100 million yuan by 2023. Continue to improve the transformation of the big health strategy After years of development, Buchang Pharmaceuticals has formed a three-dimensional product pattern with patented Chinese patent medicines as the core, based on the cardio-cerebral vascular market, covering traditional advantages of Chinese patent medic

24 2021.09

7 departments issued notices to support the development of Chinese medicine in the country. The 2 trillion market needs to be stepped up to tap the value of pharmaceuticals

Accelerate the restoration and reconstruction of Zhang Zhongjing University of Traditional Chinese Medicine

On September 18, Vice Governor Huo Jinhua went to Nanyang to investigate the restoration and reconstruction work of Zhang Zhongjing University of Traditional Chinese Medicine. Hawking walked into the Medical Sacred Shrine, Zhang Zhongjing National Medical University History Museum and other places to learn more about Zhang Zhongjing’s life and his contribution to the development of Chinese medicine. At the Nanyang Institute of Technology Zhang Zhongjing College of Traditional Chinese Medicine and Chinese Medicine and Nanyang Medical College, I asked Zhang Zhongjing about the restoration and reconstruction work of Zhang Zhongjing University of Traditional Chinese Medicine and inspected the initial campus on the spot. Huo Jinhua pointed out that it is necessary to thoroughly study and implement the important speech and instruction spirit of General Secretary Xi Jinping on the work of Chinese medicine during the investigation and study in Nanyang, deeply understand the significance of vigorously developing the cause of Chinese medicine, and earnestly inherit, carry forward and pass on the culture of Chinese medicine. good. To further polish up the "Zhongjing" brand, on the basis of inheriting the essence, keeping integrity and innovation, insisting on serving the past as the present, strengthening communication and integration, and promoting Nanyang traditional Chinese medicine culture at home and abroad. Huo Jinhua said that the restoration and reconstruction of Zhang Zhongjing University of Traditional Chinese Medicine has far-reaching significance. It is necessary to make full use of Nanyang's high-quality resources, accelerate the restoration and reconstruction work, and strive to build a first-class Chinese medicine research and education institution of higher learning in China. (Reporter: Meng Xiangdong, Henan Newspaper reporter Wang Juan)

23 2021.09

Accelerate the restoration and reconstruction of Zhang Zhongjing University of Traditional Chinese Medicine

Facing the future, Fussen Pharmaceutical Co., Ltd. is striving to revitalize national medicine as its mission

Henan Fusen Pharmaceutical Co., Ltd. was listed on the main board of the Hong Kong Stock Exchange in 2018 with stock code: 1652.HK. It is a modern comprehensive pharmaceutical company integrating medicinal plant cultivation, drug research and development, production and operation. Since its establishment in 2003, the company has been adhering to the concept of "honesty and trustworthiness, solid foundation, brand wins, and steady development", adheres to the road of "quality, technology and talents", and constantly improves the industrial chain and optimizes Internal and external resources, successively controlled the pharmaceutical research and development company Beijing Sanye Mingming Pharmaceutical Technology Co., Ltd. and the pharmaceutical distribution company Jiangxi Yongfeng Kangde Pharmaceutical Co., Ltd., and formed strategic alliances with China Resources Pharmaceutical Business Group and Jointown Pharmaceutical Group to form production, research and development, The three major areas of sales have a good development trend of "troika and synergy". It has successively won the titles of the National "Agricultural Industrialization Leading Enterprise" and Henan Province "Excellent Private Enterprise", "High-tech Enterprise", "Hundred High Enterprise" and Nanyang City's Backbone Enterprise and Top Ten Enterprise. Ingenuity quality, perfection. The company has always adhered to the pharmaceutical concept of "survive by quality". With the help of the rich resources of Chinese medicinal materials in the Funiu Mountain of 800 miles and the advantages of the first-class water quality resources in the Danjiang Reservoir of the South-to-North Water Diversion, the company has established a GAP planting base for Chinese medicinal materials to ensure product quality from the source. In strict accordance with the requirements of the national GMP production standards, we continuously optimize the production process, strictly control the process, and use ingenuity to cast drugs that "make people feel at ease". The company's existing product treatment areas cover heat-clearing and detoxifying products, cardiovascular and cerebrovascular products, blood pressure and blood sugar reduction, tonic, qi regulation, anti-anemia, antibacterial and anti-inflammatory products, among which heat-clearing products Shuanghuanglian Oral Liquid, Shuanghuanglian Injection The sales volume of liquid sheet products ranks among the top three of similar products in the country for many consecutive years. They are "National Conformity Assessment and Quality Reliable Products" and "High Quality Products in Henan Province"; Cardiovascular and cerebrovascular products, Flunarizine Hydrochloride Capsules, are the first imitation products in the country. , Ranking first in the domestic sales of similar products for five consecutive years; three exclusive varieties of Qi-regulating products Yuanhu Zhitong Oral Liquid, Ganweikang Tablets and Cardio-Cerebrovascular Products Yixinkang Tablets have been included in the national protection of traditional Chinese medicine. Technology is the foundation, innovation is the soul. The company always stands at the forefront of medical technology, adheres to the innovative development strategy, implements the policy of "integration of Chinese and Western, combination of long and short, and combination of imitation and innovation", and takes the road of new drug development of "generation of production, generation of reserves, generation of research and innovation", and research and development Innovation is the strategic basis for the high-quality development of the company. Fussen (Shenzhen) Biomedical R&D Co., Ltd. and Fussen (Macau) Co., Ltd. have been established successively, as R&D centers in the field of improved and innovative drugs, and continue to strengthen R&D capabilities and broaden product portfolios. To create a "health industry group integrating medicine, chemical medicine and biopharmaceuticals". Under the background of healthy China, the company will adhere to the corporate philosophy of "ingenuity quality • health is a blessing", taking science and technology as the forerunner, based on the traditional Chinese medicine industry, absorbing modern technology, and casting a healthy character, determined to create a century-old Fussen, a century-old brand, and Contribute to the development of the national pharmaceutical industry.

26 2021.08

Facing the future, Fussen Pharmaceutical Co., Ltd. is striving to revitalize national medicine as its mission